According to the most recent financial data from June 2025, the EPS for the trailing twelve months is $0.52. Bruker's EPS for 2024 amounted to $0.76, marking a drop from $2.92 in 2023. During the quarterly period ending on Jun 30, 2025, BRKR's EPS stood at $0.05.
Bruker had an annual EPS of $0.76, indicating a drop of 74% from $2.92 in 2023. For the fiscal quarter that ended on Jun 30, 2025, the per-share earnings was $0.05, showing no change from the same quarter last year. BRKR's 12-month EPS stands at $0.52 as of June 2025. Bruker's annual EPS in 2023 stood at $2.92, a 46% increase year-over-year.
Bruker has reported no change in EPS over the last 12 months (YoY, quarterly). In the last three years, BRKR recorded an average annual EPS growth rate of -25.4%. Bruker had an average annual EPS growth rate of -9.8% during the last 5 years. Across the last decade, BRKR had an average annual EPS growth of 8.4%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| ILMN Illumina Inc | 27.39 | -4.8% | N/A | N/A |
| AME Ametek Inc | 31.19 | 4.4% | 11.5% | 9.5% |
| TMO Thermo Fisher Scientific Inc | 32.74 | 6.8% | -5.5% | 12.4% |
| WAT Waters Corp | 34.09 | -1.1% | -1.5% | 4.2% |
| A Agilent Technologies Inc | 34.29 | 5.2% | 3.7% | 5.4% |
| GE General Electric Co | 40.36 | -28.4% | N/A | N/A |
| DHR Danaher Corp | 43.49 | -17.2% | -15.3% | 5.3% |
| BRKR Bruker Corp | 77.31 | -74% | -25.4% | -9.8% |
| BIO Bio-Rad Laboratories Inc | N/A | -199.5% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.